Ivermectin Dose For COVID (Prophylaxis, Acute Disease, Long Haulers) - YouTube
In this talk, we will discuss the possible dose of Ivermectin for prophylaxis, during the acute disease, and for the long haulers.
We will look at the dosage used by various studies, myself for my patients, and recommended by the physicians at FLCCC.net.
Note: this is not a prescription. This material is for the educational purpose only.
Ivermectin Works For COVID-19 - LATEST STUDIES - YouTube
Ivermectin Works For COVID-19 - LATEST STUDIES
More lectures on drbeen.com
Looking to support my educational work? Donate here:
https://paypal.me/mobeensyed?locale.x=en_US
Start your free trial - no credit card needed:
https://members.drbeen.com/freetrial
Original in-vitro study about Ivermectin
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7129059/
A study from bangladesh found that Ivermectin + Doxyclyclin significantly reduces mortality and morbidity in COVID-19 patients.
https://clinicaltrials.gov/ct2/show/study/NCT04523831
A systemic review of the antiviral activity of Ivermectin
https://www.nature.com/articles/s41429-020-0336-z
https://journal.chestnet.org/article/S0012-3692(20)34898-4/fulltext
PDF for the above study after it was accepted
https://journal.chestnet.org/article/S0012-3692(20)34898-4/pdf
Pre-print of the above study
https://www.medrxiv.org/content/10.1101/2020.06.06.20124461v2
A search of various Ivermectin studies for your reading pleasure
https://clinicaltrials.gov/ct2/results?cond=Covid19&term=ivermectin&cntry=&state=&city=&dist=
Iota carrageenan and Ivermectin oral drops
https://clinicaltrials.gov/ct2/show/results/NCT04425850?term=ivermectin&cond=Covid19&draw=2
Microvascular dysfunction in COVID-19 the MYSTIC study SpringerLink
Rationale Pre-clinical and autopsy studies have fueled the hypothesis that a dysregulated vascular endothelium might play a central role in the pathogenesis of ARDS and multi-organ failure in COVID-19. Objectives To comprehensively characterize and quantify microvascular alterations in patients with COVID-19. Methods Hospitalized adult patients with moderate-to-severe or critical COVID-19 (n = 23) were enrolled non-consecutively in this prospective, observational, cross-sectional, multi-center study. Fifteen healthy volunteers served as controls. All participants underwent intravital microscopy by sidestream dark field imaging to quantify vascular density, red blood cell velocity (VRBC), and glycocalyx dimensions (perfused boundary region, PBR) in sublingual microvessels. Circulating levels of endothelial and glycocalyx-associated markers were measured by multiplex proximity extension assay and enzyme-linked immunosorbent assay. Measurements and main results COVID-19 patients showed an up to 90% reduction in vascular density, almost exclusively limited to small capillaries (diameter 4–6 µm), and also significant reductions of VRBC. Especially, patients on mechanical ventilation showed severe glycocalyx damage as indicated by higher PBR values (i.e., thinner glycocalyx) and increased blood levels of shed glycocalyx constituents. Several markers of endothelial dysfunction were increased and correlated with disease severity in COVID-19. PBR (AUC 0.75, p = 0.01), ADAMTS13 (von Willebrand factor-cleaving protease; AUC 0.74, p = 0.02), and vascular endothelial growth factor A (VEGF-A; AUC 0.73, p = 0.04) showed the best discriminatory ability to predict 60-day in-hospital mortality. Conclusions Our data clearly show severe alterations of the microcirculation and the endothelial glycocalyx in patients with COVID-19. Future therapeutic approaches should consider the importance of systemic vascular involvement in COVID-19.
Nebulizing Magnesium and other natural medicinals as Iodine, Sodium Bicarbonate, peroxide and glutathione are strong treatment options that deliver the medicinals directly to the tracheobronchial tree.
(PDF) Glucosamine a multifaceted chemical entity that needs a spotlight for COVID 19 management
Request PDF | On Aug 11, 2020, Pratik M Tailor published Glucosamine a multifaceted chemical entity that needs a spotlight for COVID 19 management | Find, read and cite all the research you need on ResearchGate
A Comprehensive Literature Review on the Clinical Presentation, and Management of the Pandemic Coronavirus Disease 2019 (COVID-19)
Coronavirus disease 2019 (COVID-19) is a declared global pandemic. There are multiple parameters of the clinical course and management of the COVID-19 that need optimization. A hindrance to this development is the vast amount of misinformation present ...
Alterations in Gut Microbiota of Patients With COVID-19 During Time of Hospitalization - Gastroenterology
Although severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infects gastrointestinal tissues, little is known about the roles of gut commensal microbes in susceptibility to and severity of infection. We investigated changes in fecal microbiomes of patients with SARS-CoV-2 infection during hospitalization and associations with severity and fecal shedding of virus.
Azithromycin and Glucosamine May Amplify the Type 1 Interferon Response to RNA Viruses in a Complementary Fashion - ScienceDirect
Previous research demonstrates that, in clinically relevant concentrations, azithromycin can boost the ability of RNA viruses to induce type 1 interfe…
Bicarbonate Proves to be Cheapest Fastest Safest COVID Treatment
One does not have to be an anti-vaxxer to see and understand that COVID vaccines are not needed. They are not required legally or for any medical or public health reason to treat or prevent COVID-19. There is a broad range of both natural and pharmaceutical treatments widely available, many already proven to be very... View Article
NEW Study Shows HYDR0XYCHL0R0QUlNE Cuts COVID Death Rate In Half - YouTube
It is the most controversial word on social media HYDR0X0YCHL0RQUlNE.What is the truth about this drug? Turns out there was a study done in 2005 that found it could treat another C0R0NAVlRUS known as SARS and there has now been a full peer reviewed study that proves HCQ actually cut the death rate in half. Watch and share this video before its taken down!
Support our new free speech platform https://ISE.Media
----------------
Support Truth in Media by visiting our sponsors:
New Free Speech Platform ISE.Media https://ISE.Media
Pulse Cellular: Use code "TRUTH" for 10% every plan for life.
https://truthinmedia.com/phone
Pure VPN: Military grade vpn protection.
https://truthinmedia.com/vpn
Brave Browser: Open source and built by a team of privacy focused, performance oriented pioneers of the web.
https://truthinmedia.com/brave
#benswann
A global push to slow the spread of the coronavirus has put more than 1.7 billion people confined to their homes. All of these people need some simple treatments they can do. The perfect treatments for coronavirus need to be safe, widely available, inexpensive, easy to administer and of course effective. The good news is... View Article
COVID-19 hemoglobin, iron, and hypoxia beyond inflammation. A narrative review
Coronavirus disease-19 (COVID-19) has been regarded as an infective-inflammatory disease, which affects mainly lungs. More recently, a multi-organ involvement has been highlighted, with different pathways of injury. A hemoglobinopathy, hypoxia and cell ...
Nutrients Free Full-Text Vitamin C—An Adjunctive Therapy for Respiratory Infection, Sepsis and COVID-19 HTML
There are limited proven therapies for COVID-19. Vitamin C’s antioxidant, anti-inflammatory and immunomodulating effects make it a potential therapeutic candidate, both for the prevention and amelioration of COVID-19 infection, and as an adjunctive therapy in the critical care of COVID-19. This literature review focuses on vitamin C deficiency in respiratory infections, including COVID-19, and the mechanisms of action in infectious disease, including support of the stress response, its role in preventing and treating colds and pneumonia, and its role in treating sepsis and COVID-19. The evidence to date indicates that oral vitamin C (2–8 g/day) may reduce the incidence and duration of respiratory infections and intravenous vitamin C (6–24 g/day) has been shown to reduce mortality, intensive care unit (ICU) and hospital stays, and time on mechanical ventilation for severe respiratory infections. Further trials are urgently warranted. Given the favourable safety profile and low cost of vitamin C, and the frequency of vitamin C deficiency in respiratory infections, it may be worthwhile testing patients’ vitamin C status and treating them accordingly with intravenous administration within ICUs and oral administration in hospitalised persons with COVID-19.
Shop Discount vitamins & supplements, natural health products, organic foods and more at best prices. Money back guarantee! Shop online or call 1-800-824-4491.